Two strategies for managing invasive aspergillosis: A decision analysis

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1148-1154

  Severens, Johan L ^b   Donnelly, J Peter ^b   Meis, Jacques F G M ^b   De Vries Robbé, Pieter F ^b   De Pauw, Ben E ^b   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE COST; HUMAN; LUNG ASPERGILLOSIS; MEDICAL DECISION MAKING; PREVALENCE; PRIORITY JOURNAL;

EID: 0030778752     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516085     Document Type: Article

References (21)

1. Aisner J, Schimpff SC, Wiemik PH. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977;86:539-43.
2. Denning DW. Treatment of invasive aspergillosis. J Infect 1994;28(suppl 1):25-33.
3. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51.
4. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized, placebo-controlled, double blind, multicenter trial. Ann Intern Med 1993;118:495-503.
5. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996;22(suppl 2):S133-44.
6. Ng TTC, Denning DW. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections: evaluation of United Kingdom compassionate use data. Arch Intern Med 1995;155:1093-8.
7. Hiemenz JW, Lister J, Anaissie EJ, et al. Emergency-use amphotericin B lipid complex (ABLC) in the treatment of patients with aspergillosis: historical-control comparison with amphotericin B [abstract no 3383]. Blood 1995;86(suppl 1):849a.
8. Stynen D, Goris A, Sarfati J, Latgé JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500.
9. Verweij PE, Stynen D, Rijs AJMM, de Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33:1912-4.
10. Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-7.
11. Sulahian A, Tabouret M, Ribaud J, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996;15:139-45.
12. Poirot JL, Isnard F, Lesage S, Tabouret M. Detection of Aspergillus galactomannan in sera from hematological patients by ELISA [abstract no 3.21]. Program and abstracts of the third meeting of the European Confederation of Medical Mycology (Lisbon). 1996.
13. Tabone MD, Vu Thien H, Latgé JP, Landman-Parker J, Leverger G. Galactomannan detection by sandwich enzyme-linked immunosorbent assay in the diagnosis and follow-up of invasive aspergillosis [abstract no 3.22]. Program and abstracts of the third meeting of the European Confederation of Medical Mycology (Lisbon). 1996.
14. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign and the role of CT in early diagnosis. Radiology 1985;157:611-4.
15. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
16. Rubin RH, Fischman AJ. Radionuclide imaging of infection in the immunocompromised host. Clin Infect Dis 1996;22:414-22.
17. Oyen WJG, Claessens RAMJ, Raemaekers JMM, de Pauw BE, van der Meer JWM, Corstens FHM. Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G. J Clin Oncol 1992;10:61-8.
18. McNeil BJ, Pauker SG. Decision analysis for public health: principles and illustrations. Ann Rev Publ Health 1984;5:135-61.
19. Verweij PE, Donnelly JP, De Pauw BE, Meis JFGM. Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient. Rev Med Microbiol 1996;7:105-13.
20. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32.
21. Swanink CM, Meis JFGM, Rijs AJMM, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257-60.